Respiratory syncytial virus (RSV)
Clinical trials for Respiratory syncytial virus (RSV) explained in plain language.
Never miss a new study
Get alerted when new Respiratory syncytial virus (RSV) trials appear
Sign up with your email to follow new studies for Respiratory syncytial virus (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new vaccine shield adults from RSV?
Vaccine Not yet recruitingResearchers are testing an experimental vaccine against respiratory syncytial virus (RSV) in adults aged 18 and older. The trial aims to see if the vaccine is safe and whether it triggers an immune response. Participants receive one of several vaccine formulations or a placebo, a…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase 1 • Sponsor: Yikang Biotech (Suzhou) Co., Ltd. • Aim: Vaccine
Last updated Sep 10, 2026 00:00 UTC
-
Scientists test RSV vaccine to boost immune memory
Vaccine Not yet recruitingThis study will test a new RSV vaccine in 60 adults aged 20 and older. Researchers want to understand how the vaccine triggers the immune system to create strong antibodies and memory T cells. The goal is to learn how to make RSV vaccines more effective.
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
New RSV vaccine trial aims to protect women from respiratory virus
Vaccine Not yet recruitingThis early-stage study tests a new vaccine (MKK900) against respiratory syncytial virus (RSV) in 120 healthy women aged 18 to 49. The main goal is to check if the vaccine is safe and triggers a strong immune response. Participants will receive either the new vaccine or an active …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase 1 • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: Vaccine
Last updated Jun 27, 2026 12:00 UTC
-
Pregnancy shot may shield newborns from deadly RSV – major brazil trial launches
Vaccine Not yet recruitingThis study will check how well a new RSV vaccine (RSVpreF) works when given to pregnant women in Brazil. Researchers will follow 5,000 infants up to 6 months old who are hospitalized or seen in clinics for respiratory illness. By comparing babies whose mothers got the vaccine to …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Sponsor: Inova Medical • Aim: Vaccine
Last updated Jun 27, 2026 09:09 UTC
-
Can an inhaled drug tame RSV symptoms in adults?
Disease control Not yet recruitingThis phase 2 trial tests an inhaled drug called YKYY018 in adults with respiratory syncytial virus (RSV) infection. The goal is to see if the drug can shorten the time until lower respiratory symptoms, like cough and wheezing, improve. Participants receive either YKYY018 or a pla…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase 2 • Sponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
One shot to stop RSV: landmark trial for indigenous kids
Prevention Not yet recruitingThis study tests whether a single dose of nirsevimab, an antibody that targets RSV, can prevent respiratory infections in Aboriginal and Torres Strait Islander children aged 6 months. Around 1,000 children will be randomly assigned to receive either the antibody or standard care.…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase 4 • Sponsor: Menzies School of Health Research • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
New RSV shot for babies enters early human trials
Prevention Not yet recruitingThis study tests a new medicine called SIBP-A16 to see if it can safely prevent RSV in infants under 1 year old, including those born early. About 36 babies will receive either the new drug, a placebo, or an existing RSV drug. The main goal is to check for side effects and how th…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase 1/2 • Sponsor: Shanghai Institute Of Biological Products • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
The Little-Known virus that may rival RSV and flu in older adults
Knowledge-focused Not yet recruitingResearchers are tracking 1,000 hospitalized patients aged 65 and older who test positive for a respiratory virus, including human metapneumovirus (hMPV), influenza, RSV, and others. The study compares how each virus relates to death, organ complications, loss of independence, and…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC